EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Adjuvant therapy with edrecolomab versus observation in stage II colon cancer: a multicenter randomized phase III study



Adjuvant therapy with edrecolomab versus observation in stage II colon cancer: a multicenter randomized phase III study



Onkologie 28(6-7): 347-350



Background: In a phase III study recruiting patients with stage II colon cancer the effect of adjuvant therapy with edrecolomab, a murine monoclonal antibody to the cell-surface glycoprotein 17-1A, was compared to observation alone. Patients and Methods: From January 1997 until July 2000 a total of 377 patients were postoperatively stratified according to tumor stage (T3 vs.

(PDF emailed within 0-6 h: $19.90)

Accession: 011731827

Download citation: RISBibTeXText

PMID: 15933423

DOI: 10.1159/000084595



Related references

Edrecolomab (Panorex) as adjuvant therapy for stage II colon cancer. Clinical Colorectal Cancer 1(1): 16-17, 2002

CMF versus CNF as adjuvant chemotherapy for stage II lymph-node positive breast cancer A phase III randomized multicenter study. American Journal of Clinical Oncology 24(4): 323-327, August, 2001

Adjuvant therapy with the monoclonal antibody Edrecolomab plus fluorouracil-based therapy does not improve overall survival of patients with stage III colon cancer. Journal of Clinical Oncology 27(12): 1941-1947, 2009

Edrecolomab alone or in combination with fluorouracil and folinic acid in the adjuvant treatment of stage III colon cancer: a randomised study. Lancet 360(9334): 671-677, 2002

Mature results of a phase III randomized trial of bacillus Calmette-Guerin versus observation and BCG plus dacarbazine versus BCG in the adjuvant therapy of American Joint Committee on Cancer Stage I-III melanoma - A trial of the eastern cooperative oncology group. Cancer 100(8): 1692-1698, April 15, 2004

Mature results of a phase III randomized trial of bacillus Calmette-Guerin (BCG) versus observation and BCG plus dacarbazine versus BCG in the adjuvant therapy of American Joint Committee on Cancer Stage I-III melanoma (E1673): a trial of the Eastern Oncology Group. Cancer 100(8): 1692-1698, 2004

Mature results of a phase III randomized trial of bacillus Calmette-Guerin (BCG) versus observation and BCG plus dacarbazine versus BCG in the adjuvant therapy of American Joint Committee on Cancer Stage I-III melanoma (E1673) - A trial of the eastern cooperative oncology group. Cancer 100(8): 1692-1698, 2004

Adjuvant therapy with fluorouracil and oxaliplatin in stage II and elderly patients (between ages 70 and 75 years) with colon cancer: subgroup analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer trial. Journal of Clinical Oncology 30(27): 3353-3360, 2012

A randomized phase III trial of postoperative adjuvant therapy with S-1 alone versus S-1 plus PSK for stage II/IIIA gastric cancer: Hokuriku-Kinki Immunochemo-Therapy Study Group-Gastric Cancer (HKIT-GC). Japanese Journal of Clinical Oncology 36(8): 519-522, 2006

CONKO-001: Final results of the randomized, prospective, multicenter phase III trial of adjuvant chemotherapy with gemcitabine versus observation in patients with resected pancreatic cancer (PC). Journal of Clinical Oncology 26(15_suppl): Lba4504-Lba4504, 2016

CMF (cyclophosphamide, methotrexate, 5-fluorouracil) versus cnf (cyclophosphamide, mitoxantrone, 5-fluorouracil) as adjuvant chemotherapy for stage II lymph-node positive breast cancer: a phase III randomized multicenter study. American Journal of Clinical Oncology 24(4): 323-327, 2001

Documenting the natural history of patients with resected stage II adenocarcinoma of the colon after random assignment to adjuvant treatment with edrecolomab or observation: results from CALGB 9581. Journal of Clinical Oncology 29(23): 3146-3152, 2011

S-1 as adjuvant chemotherapy for stage III colon cancer: a randomized phase III study (ACTS-CC trial). Annals of Oncology 25(9): 1743-1749, 2015

Adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma: a phase III randomized controlled trial of health-related quality of life and symptoms by the European Organisation for Research and Treatment of Cancer Melanoma Group. Journal of Clinical Oncology 27(18): 2916-2923, 2009